George S Stergiou is an expert in Cardiology at Sotiria General Hospital (Greece). As of October 2026, ScienceLeadR ranks George S Stergiou in the top 1% of experts worldwide for Hypertension. George S Stergiou has authored 661 publications, the most recent in 2026, and is an investigator in 16 clinical trials, 1 of them ongoing. SLR score: 2,242 (community average: 125). How the SLR is computed.

LeadR Profile

George S Stergiou Sotiria General Hospital Greece
2 242 ScienceLeadR Reputation 2242
Network Map

Cardiology

Subspecialties: Hematology - Public Health - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1993 - 2026

Source: PubMed

National and Kapodistrian University of Athens

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 661

Citations

Citations: 61 733 1st author: 187 Last author: 209 Unique author: 20


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Update of the practical guide for validation studies of automated cuff blood pressure monitors according to the Universal Standard by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (ISO 81060-2:2018) and Amendments 1:2020 and 2:2024.
PMID 42853222 — hypertension, blood pressure monitors, blood, blood pressure
J Hypertens20260
Hypertension phenotypes in nondialysis patients with chronic kidney disease: systematic review and meta-analysis.
PMID 42853207 — kidney diseases, hypertension, blood, blood pressure, phenotype, masked hypertension, kidney, prevalence, blood pressure monitoring, ambulatory, records
J Hypertens20260
Hypertensive disorders of pregnancy and the risk for hypertension and cardiovascular and kidney disease. International Society of Hypertension position paper, endorsed by the World Hypertension League and European Society of Hypertension.
PMID 42695459 — kidney diseases, hypertension, pregnancy, mortality, vascular endothelial growth factor a, blood pressure, kidney, lupus erythematosus, systemic, morbidity, fetal growth retardation, diabetes mellitus, type 1
J Hypertens20260
Professor John Low Reid, OBE, DM, FRCP, FRSE, FMedSci.
PMID 42644446 — hypertension
J Hypertens20260
Nighttime blood pressure versus non-dipping for predicting asymptomatic organ damage in young individuals.
PMID 42644440 — hypertension, blood, blood pressure, sex, child
J Hypertens20260

Clinical Studies 16

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5 Study Chair: 5

By phase:

N/A 11
Phase 4 3
Phase 3 2

By status:

Completed 7
Unknown 7
Active not recruiting 1
Recruiting 1

By type:

Interventional 8
Observational 8

By Monocentric/Multicentric:

monocentric 10
multicentric2to4 4
multicentric5to9 0
multicentricup10 2

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Effects of the combination of two drugs called irbesartan and amlodipine in one pill in patients with high blood pressure
2024-511705-31-00 — hypertension, safety, blood, pharmaceutical preparations, blood pressure, irbesartan, amlodipine
Phase 3Active not recruiting2024

LeadR Networks

Main global connection map